On January 27, 2023,  the Food and Drug Administration approved a new targeted therapy for hard-to-treat advanced breast cancers. Its development was made possible by research and advocacy from the lab of Donald McDonnell, PhD, in the Department of Pharmacology and Cancer Biology. 

Through her research and administrative work, Sherilynn Black has developed expertise in what scholars need to thrive in academic careers. Recognized as a national leader, she will guide a new initiative at the National Academies of Sciences, Engineering and Medicine on mentorship, professional development and well-being.

Popular TikTok videos that highlight ways to obtain a medication abortion are typically informative and useful, according to a study led by Duke Health researchers.

Production will enable human studies to determine whether the vaccine protects against a wide variety of coronaviruses, including those that cause COVID-19 

Pathogenic fungi (Candida, Aspergillus, Cryptococcus and others) are notorious killers of immune-compromised people. But for the most part, healthy people have not had to worry about them, and the vast majority of the planet’s potentially pathogenic fungi don’t do well in the heat of our bodies. But all that may be about to change.

A 10-year partnership between the Department of Pathology and Duke Cancer Institute has helped researchers make advances in human tissue-based research and cancer precision medicine.

Two members of the Duke University School of Medicine faculty have been elected as 2022 fellows by the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.   

Duke University School of Medicine is withdrawing from the annual U.S. News & World Report rankings of medical schools, Dean Mary E. Klotman, MD, and Vice Dean for Education Edward Buckley, MD, said Friday.

Major donors Todd Brady, (MD’99, PhD’98) and Andrea Darling (MA’96, JD’99), a married couple of 26 years whose son, Alex, started as a freshman at Duke University in the fall of 2022, describe their path around Duke being connected by mentors, explained why they choose to give back, and shared what they hope to accomplish through their philanthropy.

Active participants in Law Enforcement Assisted Diversion were significantly less likely to be re-arrested and more likely to use behavioral health treatment, according to a study of four programs in North Carolina.